170 related articles for article (PubMed ID: 36482181)
21. A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy.
Zeng Z; Hu C; Ruan W; Zhang J; Lei S; Yang Y; Peng P; Pan F; Chen T
Front Immunol; 2022; 13():1001381. PubMed ID: 36159801
[TBL] [Abstract][Full Text] [Related]
22. N7-methylguanosine methylation-related regulator genes as biological markers in predicting prognosis for melanoma.
Deng J; Lin J; Liu C; Li J; Cai J; Zhou X; Li X
Sci Rep; 2022 Dec; 12(1):21082. PubMed ID: 36473947
[TBL] [Abstract][Full Text] [Related]
23. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.
Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B
Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976
[TBL] [Abstract][Full Text] [Related]
24. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Yang KS; Xu CQ; Lv J
Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
[TBL] [Abstract][Full Text] [Related]
25. A genomic instability-related lncRNA model for predicting prognosis and immune checkpoint inhibitor efficacy in breast cancer.
Jiao Y; Li S; Wang X; Yi M; Wei H; Rong S; Zheng K; Zhang L
Front Immunol; 2022; 13():929846. PubMed ID: 35990656
[TBL] [Abstract][Full Text] [Related]
26. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
Yue Y; Zhang Q; Sun Z
Front Immunol; 2021; 12():758040. PubMed ID: 35140706
[TBL] [Abstract][Full Text] [Related]
27. Establishment and Validation of a Genetic Label Associated With M2 Macrophage Infiltration to Predict Survival in Patients With Colon Cancer and to Assist in Immunotherapy.
Xu B; Peng Z; Yan G; Wang N; Chen M; Yao X; Sun M; An Y
Front Genet; 2021; 12():726387. PubMed ID: 34552622
[TBL] [Abstract][Full Text] [Related]
28. Identification of genes modified by N6-methyladenosine in patients with colorectal cancer recurrence.
Zhu Q; Huang X; Yu S; Shou L; Zhang R; Xie H; Liang Z; Sun X; Feng J; Duan T; Zhang M; Xiang Y; Sui X; Jin W; Yu L; Wu Q
Front Genet; 2022; 13():1043297. PubMed ID: 36324506
[No Abstract] [Full Text] [Related]
29. Identifying and Validating an Acidosis-Related Signature Associated with Prognosis and Tumor Immune Infiltration Characteristics in Pancreatic Carcinoma.
Tang P; Qu W; Wu D; Chen S; Liu M; Chen W; Ai Q; Tang H; Zhou H
J Immunol Res; 2021; 2021():3821055. PubMed ID: 34993253
[TBL] [Abstract][Full Text] [Related]
30. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
31. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
32. A Prognostic Model Using Immune-Related Genes for Colorectal Cancer.
Feng W; Zhang Y; Liu W; Wang X; Lei T; Yuan Y; Chen Z; Song W
Front Cell Dev Biol; 2022; 10():813043. PubMed ID: 35252182
[TBL] [Abstract][Full Text] [Related]
33. Mapk14 is a Prognostic Biomarker and Correlates with the Clinicopathological Features and Immune Infiltration of Colorectal Cancer.
Wang D; Peng L; Hua L; Li J; Liu Y; Zhou Y
Front Cell Dev Biol; 2022; 10():817800. PubMed ID: 35141222
[No Abstract] [Full Text] [Related]
34. Prognostic Signatures Based on Thirteen Immune-Related Genes in Colorectal Cancer.
Ma XB; Xu YY; Zhu MX; Wang L
Front Oncol; 2020; 10():591739. PubMed ID: 33680920
[TBL] [Abstract][Full Text] [Related]
35. Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis.
Chen YF; Yu ZL; Lv MY; Cai ZR; Zou YF; Lan P; Wu XJ; Gao F
Mol Med; 2021 Oct; 27(1):139. PubMed ID: 34717544
[TBL] [Abstract][Full Text] [Related]
36. Construction of a Novel Immune-Related mRNA Signature to Predict the Prognosis and Immune Characteristics of Human Colorectal Cancer.
Li J; Han T; Wang X; Wang Y; Chen X; Chen W; Yang Q
Front Genet; 2022; 13():851373. PubMed ID: 35401707
[No Abstract] [Full Text] [Related]
37. Prognostic Model of Colorectal Cancer Constructed by Eight Immune-Related Genes.
Wen S; He L; Zhong Z; Mi H; Liu F
Front Mol Biosci; 2020; 7():604252. PubMed ID: 33330631
[TBL] [Abstract][Full Text] [Related]
38. Development of an Immune Infiltration-Related Eight-Gene Prognostic Signature in Colorectal Cancer Microenvironment.
Wu B; Tao L; Yang D; Li W; Xu H; He Q
Biomed Res Int; 2020; 2020():2719739. PubMed ID: 32908876
[TBL] [Abstract][Full Text] [Related]
39. Computational profiling and prognostic modeling based on lysosome-related genes in colorectal cancer.
Zhang L; Yang J; Deng Y; Deng W; Li L
Front Genet; 2023; 14():1203035. PubMed ID: 38075693
[No Abstract] [Full Text] [Related]
40. A novel Anoikis and immune-related genes marked prognostic signature for colorectal cancer.
Cai Z; Zhou F
Medicine (Baltimore); 2022 Nov; 101(46):e31127. PubMed ID: 36401385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]